Depression and coronary heart disease.
Robert M Carney1, Kenneth E Freedland1
1Washington University School of Medicine, 4320 Forest Park Avenue, Suite 301, St. Louis, Missouri 63108, USA.
Nature Reviews. Cardiology
|November 18, 2016
Summary
Depression significantly increases coronary heart disease (CHD) risk. While treating depression hasn't improved cardiac outcomes, improved depression suggests better patient prognosis.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Depression is a major risk factor for coronary heart disease (CHD) and adverse cardiovascular outcomes.
- Hypothesized biobehavioral mechanisms linking depression and CHD explain only a small portion of the risk.
- Few clinical trials have investigated if depression treatment improves cardiac events in CHD patients.
Purpose of the Study:
- To review the evidence on the relationship between depression and coronary heart disease (CHD).
- To assess the impact of depression treatment on cardiac outcomes in patients with established CHD.
- To identify future research directions for understanding and managing depression in CHD.
Main Methods:
- Review of existing clinical trials and secondary analyses examining depression treatment in CHD patients.
- Analysis of hypothesized biological and behavioral mechanisms linking depression to CHD.
- Synthesis of current evidence to guide future research and clinical practice.
Main Results:
- Current depression treatments have not demonstrated improved cardiac outcomes in patients with established CHD.
- Secondary analyses suggest a potential link between improved depression and better patient prognosis.
- The direct impact of depression treatment on cardiac events remains inconclusive.
Conclusions:
- More potent depression interventions are needed for patients with CHD.
- Identifying high-risk depression subtypes may improve targeted treatment efficacy.
- Further research into biobehavioral mechanisms is crucial for definitive clinical trials.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
790
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
790
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Psychoneuroimmunology: Cardiovascular Disease
644
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
644
Coronary Artery Disease II: Pathophysiology
862
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
862
Coronary Artery Disease III: Clinical Manifestations
504
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
504
Depressive Disorders: MDD and Dysthymia
975
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
975


